Urinalysis Market worth over $4.6bn by 2027

Urinalysis Market size is set to surpass USD 4.6 billion by 2027, according to a new research report by Global Market Insights Inc.
 

The market growth is attributed to the increasing incidence of urinary tract infection (UTIs) in women across the globe along with rising healthcare awareness programs. For instance, in November 2020, leaders of proactive urinary tract health, Uqora, declared November 21st as National UTI Awareness Day. UTIs are the second most common infection across the U.S. therefore, such awareness programs will help millions of people struggling with UTIs that will accelerate the market expansion.

 

Request Sample Buy NowInquiry Before Buying

 

Increasing prevalence of chronic kidney disease will spur the market progression

The rising prevalence of non-communicable diseases (NCDs) such as cardiovascular disease, cancer, chronic respiratory and several other risk factors have increased the burden of chronic kidney diseases (CKDs). As per the CDC report published in 2021, in the U.S. more than one in seven people that is 15% of U.S. adults are estimated to have chronic kidney diseases. Several other health conditions such as hypertension, diabetes, interstitial, glomerulonephritis, and vascular disease are also known to cause chronic renal diseases. Additionally, in some of the countries such as Africa, bacterial infection by streptococcal, hepatitis B and C viruses and HIV are one of the prime causes of CKD.
 

Growing adoption of automated urine analyzers will augment the market value

Global Urinalysis Market By Product

Get more details on this report - Request Free Sample PDF
 

The instruments segment accounted for around USD 940 million in 2020 led by the shift of healthcare physicians towards automated urine analyzers. These analyzers function by producing monolayer of urine sediment and the sediment is then analysed using bright field microscope and a digital camera. Thus, the integrated and automated systems for urinalysis provide convenience, efficiency, and increased sensitivity for detecting renal and urinary tract abnormalities. Furthermore, urine analyzers in the case of complicated and serious illness provide accurate test results as compared to dipsticks and reagents that fosters the industry growth.
 

Rising pregnancy rates will boost the market revenue

The pregnancy segment held more than 20% of the market share in 2020. Many countries in Sub-Saharan Africa and Asia continues to experience high fertility and pregnancy rates. Urine test is a foremost pregnancy test as in pregnant women placenta produces hCG, a pregnancy hormone. The presence of hCG in urine confirms pregnancy. Also, during pregnancy urine testing is suggested by doctors for detecting protein, ketone and sugar levels to confirm that the pregnant woman is not suffering with health conditions such as UTI, gestational diabetes, or preeclampsia.
 

Browse key industry insights spread across 200 pages with 143 market data tables & 13 figures & charts from the report, Urinalysis Market Size By Product (Consumables {Dipsticks, Reagents, Disposables}, Instruments {Biochemical Urine Analyzer, Automated Urine Sediment Analyzer}), By Application (Urinary Tract Infections, Kidney Diseases, Pregnancy, Diabetes), By End-use (Clinical Laboratories, Hospitals, Home Healthcare), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027 in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/urinalysis-market
 

Highly accurate testing’s offered in clinical laboratories will propel the market demand

The clinical laboratories segment is poised to witness 5.7% growth rate through 2027. Standardization of analytical techniques, reagents and instrumentation used in clinical laboratories have helped in lowering the analytical error in urinalysis tests performed in these labs remarkably. Also, clinical laboratories collaborate with hospital facilities and clinics for several diagnostic tests to minimize time, cost and human resources thereby, favouring the industry value. In addition, clinical laboratories provide patient related medical information to physicians and healthcare providers for accurate diagnosis and care.
 

Government funding in European countries will fuel the market growth

Europe urinalysis market is slated to attain a CAGR of 5.2% during 2021 to 2027. Establishment of R&D and government funding will secure the industry demand. For instance, with the help of the EU-funded project named DigiPee, researchers developed an in-home urinalysis device called Medipee. To provide accurate in-home medical care, researchers from the Germany and Netherlands developed Medipee to monitor hydration levels and help detect various other potential health issues.
 

Moreover, presence of established healthcare infrastructure and awareness regarding routine diagnostic tests along with growing number of pathological centers and hospitals in Europe are few aspects proving beneficial for the regional expansion.
 

Strategic initiatives undertaken by market participants will provide them competitive advantage

Some of the prominent players functioning in the market include Sysmex, Roche Diagnostics, Abbott, Bio-Rad Laboratories Inc., Erba Mannheim, Acon Laboratories, Cardinal Health, ARKKRAY USA Inc., HYCEL MEDICAL and Teco Diagnostics. These market leaders are involved in strategic partnership agreements, collaborations, and mergers to strengthen their market position.
 

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X